SARS‐CoV‐2 targets neurons of 3D human brain organoids
Open accessPublished version of a preprint
The DOI matches its Crossref record; 62 of the 63 references it cites were found in a registry or an index, and 1 are not checked yet.
Abstract
COVID-19 pandemic caused by SARS-CoV-2 infection is a public health emergency. COVID-19 typically exhibits respiratory illness. Unexpectedly, emerging clinical reports indicate that neurological symptoms continue to rise, suggesting detrimental effects of SARS-CoV-2 on the central nervous system (CNS). Here, we show that a Düsseldorf isolate of SARS-CoV-2 enters 3D human brain organoids within 2 days of exposure. We identified that SARS-CoV-2 preferably targets neurons of brain organoids. Imaging neurons of organoids reveal that SARS-CoV-2 exposure is associated with altered distribution of Tau from axons to soma, hyperphosphorylation, and apparent neuronal death. Our studies, therefore, provide initial insights into the potential neurotoxic effect of SARS-CoV-2 and emphasize that brain organoids could model CNS pathologies of COVID-19.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Notably, organoids can be cultivated over months and probably even years, thus enabling the investigation of tissue maturation in a disease context as shown for SARS-CoV-2 infections in brain organoids87”
From Human disease models in drug development (2023) · cites this paper as [87]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“SARS-CoV-2 tropism for neurons87 and cortical astrocytes88 or its preference for mature cell types and distinct neurotoxic effects were demonstrated in brain organoids.”
From Human disease models in drug development (2023) · cites this paper as [87]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N.-H., Nitsche, A., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.052 · Cited by 20,286
Yang, X., Yu, Y., Xu, J., Shu, H., Xia, J., Liu, H., Wu, Y., Zhang, L., Yu, Z., Fang, M., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30079-5 · Cited by 10,066
Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR
Corman, V. M., Landt, O., Kaiser, M., Molenkamp, R., Meijer, A., Chu, D. K., Bleicker, T., Brünink, S., Schneider, J., Schmidt, M. L., et al. (2020) · Eurosurveillance · doi:10.2807/1560-7917.es.2020.25.3.2000045 · Cited by 7,344
Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus
Li, W., Moore, M. J., Vasilieva, N., Sui, J., Wong, S. K., Berne, M. A., Somasundaran, M., Sullivan, J. L., Luzuriaga, K., Greenough, T. C., et al. (2003) · Nature · doi:10.1038/nature02145 · Cited by 5,923 · cited 7×
“ACE-2 is an entry receptor for SARS-CoV and efficient replication of SARS-CoV (SARS outbreak in the year 2003) and also depends on the expression level of ACE-2 (Li et al , 2003; Hoffmann et al , 2020).”
InfluentialCerebral organoids model human brain development and microcephaly
Lancaster, M. A., Renner, M., Martin, C.-A., Wenzel, D., Bicknell, L. S., Hurles, M. E., Homfray, T., Penninger, J. M., Jackson, A. P., & Knoblich, J. A. (2013) · Nature · doi:10.1038/nature12517 · Cited by 5,372 · cited 2×
“We adapted previously described protocol to differentiate iPSCs into brain organoids described earlier (Lancaster et al , 2013; Gabriel et al , 2016).”
Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study
Chen, T., Wu, D., Chen, H., Yan, W., Yang, D., Chen, G., Ma, K., Xu, D., Yu, H., Wang, H., et al. (2020) · BMJ · doi:10.1136/bmj.m1091 · Cited by 3,903 · cited 1×
“However, emerging case reports showed that patients infected with SARS-CoV-2 suffered a sudden and complete loss of the olfactory function, stroke, and other severe neurological symptoms (Chen et al , 2020; Helms et al , 2020; Poyiadji et al , 2020; Sedaghat & Karimi, 2020; Virani et al , 2020).”
Organogenesis in a dish: Modeling development and disease using organoid technologies
Lancaster, M. A., & Knoblich, J. A. (2014) · Science · doi:10.1126/science.1247125 · Cited by 2,931 · cited 1×
“Cortical neurons are positioned basally to the VZ, forming a cortical plate ) (Lancaster & Knoblich, 2014; Giandomenico & Lancaster, 2017; Gopalakrishnan, 2019).”
Neurologic features in severe SARS-CoV-2 infection
Helms, J., Kremer, S., Merdji, H., Clere-Jehl, R., Schenck, M., Kummerlen, C., Collange, O., Boulay, C., Fafi-Kremer, S., Ohana, M., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2008597 · Cited by 2,674
Tau in physiology and pathology
Wang, Y., & Mandelkow, E. (2016) · Nature Reviews Neuroscience · doi:10.1038/nrn.2015.1 · Cited by 2,251
Baig, A. M., Khaleeq, A., Ali, U., & Syeda, H. (2020) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.0c00122 · Cited by 2,207
Research works printed but not linked: 1
- Flint SJ, Racaniello VR, Rall GF, Skalka AM, Enquist LW (2015) Principles of virology. Washington, DC: ASM Press
Cited by
Items 401–500 of 524
Advancing virology research with a human brain organoid platform
Liu, J., Zhu, N., Huo, W., & Tan, W. (2024) · hLife · doi:10.1016/j.hlife.2024.09.003 · Cited by 3
COVID-19-Associated Encephalopathy—Case Series and Clinical Considerations
Udzik, J., Jakubowski, P., Niekrasz, M., Barczyszyn, A., & Parczewski, M. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11040981 · Cited by 3
Yepes, M. (2022) · Current Drug Targets · doi:10.2174/1389450123666220919123029 · Cited by 5
Trans-synaptic dwelling of SARS-CoV-2 particles perturbs neural synapse organization and functionPreprint
Partiot, E., Hirschler, A., Colomb, S., Lutz, W., Claeys, T., Delalande, F., Deffieu, M. S., Roels, J. R. E., Bons, J., Callon, D., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.09.13.507484 · Cited by 3
“S3D), as previously reported (23, 24), although SARS-CoV-2 cellular neurotropism is a complex question that is still under investigation (25, 26).”
MethodShull, T. L., Bhimalli, P. P., Welninski, S. J., Cho, B.-K., Mattamana, B. B., Arivalagan, J., Tarhoni, I., Goo, Y. A., Schneider, J. A., Agrawal, S., et al. (2025) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2025.03.031 · Cited by 2
Gong, J., Ge, L., Zeng, Y., Cao, Y., Luo, Y., Kang, J., Zou, T., & Xu, H. (2025) · Cell & Bioscience · doi:10.1186/s13578-025-01383-0 · Cited by 3
Post‐Covid Alzheimer and Its Remediation via PROTACs Therapy: A Comprehensive Review
Bhowmick, T., Basu, R., Mitra, A. K., Ali, S. A., Kumer, A., & Dhara, B. (2025) · Health Science Reports · doi:10.1002/hsr2.71631 · Cited by 2
Stigliano, E., Tocci, A., Florio, R., Arena, V., & Amadoro, G. (2026) · Cells · doi:10.3390/cells15020176 · Cited by 2
“In agreement, SARS-CoV-2 readily targets neurons of ACE2-expressing 3D human brain organoids, giving rise to tau hyperphosphorylation and mislocalization into soma, DNA fragmentation, and, eventually, cell death [36].”
Histopathological features of SARS-CoV-2 infection and relationships with organoid technology
İnanç, İ., & Erdemlı, E. (2021) · Journal of International Medical Research · doi:10.1177/03000605211044382 · Cited by 2
“Although SARS-CoV-2 can infect brain organoids, the virus did not efficiently replicate in this tissue, suggesting that active replication of SARS-CoV-2 may not occur in the central nervous system.(75) In another study, the effects of SARS-CoV-2 were evaluated on both single-layer neuron cell cultures and brain organo…”
Human Organoids, their Perspective, and Applications for Personalized Therapy: Rapid Review
Pratap, P. D., & Ahmad, S. (2023) · Global Journal of Medical Pharmaceutical and Biomedical Update · doi:10.25259/gjmpbu_96_2022 · Cited by 2
Danev, S., Lakey, T. R., Lakey, J. R. T., & Lakeya, J. (2022) · Neurology and Neuroscience · doi:10.33425/2692-7918.1034 · Cited by 2
3D cell cultures: prospects for use in virology
Kuznetsova, T. A., Aliev, M. R., Mikhalko, A. A., & Shchelkanov, M. Y. (2024) · Russian Journal of Infection and Immunity · doi:10.15789/2220-7619-dcc-17656 · Cited by 2
The liver as a potential gate to the brain for encephalitic viruses
Lalande, A., Canus, L., Bourgeais, A., Mathieu, C., & Ogire, E. (2025) · Current Opinion in Virology · doi:10.1016/j.coviro.2025.101463 · Cited by 2
Coupling of SARS-CoV-2 to Amyloid Fibrils and Liquid-Liquid Phase Separation
Nguyen, H. L., & Li, M. S. (2025) · Current Protein and Peptide Science · doi:10.2174/0113892037354482250414045355 · Cited by 2
SARS-CoV-2 and neurotropism: evidence, gaps and reflections
Lopes, T. R. R., Sitton, B., Pillat, M. M., Mello, C. F., Weiblen, R., Flores, E. F., & Júnior, J. V. J. S. (2025) · Journal of Medical Microbiology · doi:10.1099/jmm.0.002016 · Cited by 3
“…specifically in the CNS. Finally, we propose some deeper reflections on the SARS- CoV-2 neurotropic potential. with 2D cell culture or brain organoids have led to different findings on this issue, demonstrating or suggesting abortive or productive SARS- CoV-2 infection [4, 6, 10, 11, 19, 20].”
Emerging evidence of neuronal cells-targeting SARS-CoV-2 causing anosmia associated with COVID-19
Baig, A. M. (2022) · Neural Regeneration Research · doi:10.4103/1673-5374.344843 · Cited by 2
Brain Biomarkers in Patients with COVID-19 and Neurological Manifestations: A Narrative Review
Tyagi, M., Kapoor, I., Mahajan, C., Gupta, N., & Prabhakar, H. (2022) · Journal of Neuroanaesthesiology and Critical Care · doi:10.1055/s-0042-1744395 · Cited by 3
COVID-19 (novel SARS-CoV-2) neurological illness
Younger, D. S. (2023) · Handbook of clinical neurology · doi:10.1016/b978-0-323-98818-6.00014-5 · Cited by 2
Williams, M. E., & Fielding, B. C. (2020) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2020.0136 · Cited by 2
Rhinological manifestations of COVID-19 in adult patients
Magomedov, M. M., & Cherkasov, D. S. (2020) · Russian Rhinology · doi:10.17116/rosrino202028041231 · Cited by 2
Altern und neurodegenerative Erkrankungen – warum gehen Nervenzellen verloren?
Klimaschewski, L. P. (2021) · Springer eBooks · doi:10.1007/978-3-662-63392-2_2 · Cited by 3
Neurotropism as a Mechanism of the Damaging Action of Coronavirus
Гомазков, О. А. (2022) · Biology Bulletin Reviews · doi:10.1134/s2079086422060044 · Cited by 2
“SARS-CoV-2 exposure to the organelles of the cerebral cortex is associated with tau protein hyperphosphorylation and neuronal death (Ramani et al., 2020).”
Kettunen, P., Lesnikova, A., Räsänen, N., Ojha, R., Palmunen, L., Laakso, M., Lehtonen, Š., Kuusisto, J., Pietiläinen, O. P. H., Vapalahti, O. P., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.09.14.508057 · Cited by 2
COVID-19-Associated Encephalopathy (COVEP): Basic Aspects of Neuropathology
Stoyanov, G. S., Stoyanov, D. S., Ivanov, M. N., Tonchev, A. B., Popov, H., & Petkova, L. (2022) · Encyclopedia · doi:10.3390/encyclopedia2040122 · Cited by 3
Haverty, R., McCormack, J., Evans, C., Purves, K., O’Reilly, S. R., Gautier, V., Rochfort, K. D., Fabre, A., & Fletcher, N. F. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.11.21.568132 · Cited by 2
Post-COVID-19 Neuropathology and Perspectives of Protective Roles of Estrogens
Ureshino, R. P., Stilhano, R. S., Prado, C. M., & Newson, L. R. (2025) · COVID · doi:10.3390/covid5010009 · Cited by 1
Kettunen, P., Ruuska, J., Quirin, T., Ojha, R., Saber, S. H., Sng, J. D. J., Morrison, S. D., Al-mhanawi, B., Shaker, M. R., Neck, S. D., et al. (2025) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2025.102726 · Cited by 2
An overview on organoids—Past, present, and future scenarios of organoids
Iyer, M. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-29898-1.00007-1 · Cited by 1
Liu, J., Deng, Y. L., Huo, W., Song, J., Zhai, C., Wei, L., Wu, C., Zhang, G., Huang, B., Wang, W., et al. (2025) · Journal of Biomedical Science · doi:10.1186/s12929-025-01193-z · Cited by 1
All-in-one generation and multiomic profiling of human whole brain organoid on a millifluidic plate
Zhao, W., Wang, Y., Chen, T., Shen, M., Wang, J., Huang, X., Zhu, L., Yu, T., Zhang, Z., Yang, Y., et al. (2025) · Materials Today Bio · doi:10.1016/j.mtbio.2025.102653 · Cited by 5
PRICE, M., & Pistollato, F. (2026) · Frontiers in Toxicology · doi:10.3389/ftox.2025.1753572 · Cited by 2
“Neuronal tau hyperphosphorylation and translocation to the soma is also observed (Ramani et al., 2020), highlighting how organoid models can be leveraged to disentangle the cellular and molecular mechanisms of viral infection in the human brain and its potential role in AD onset.”
Zhang, W., Wang, T. W., Yao, M., Su, L., Xie, L., & Pan, P. (2026) · Open Research (University of Surrey) · doi:10.1002/viw.20250207 · Cited by 2
Brain organoids and brain disease organoids modeling in the age of artificial intelligence
Long, J., & Han, X. (2026) · Cell organoid (Print) · doi:10.26599/co.2026.9410024 · Cited by 1
COVID-19 Infection and Neuropathological Features
Freire‐de‐Lima, L., Scovino, A. M., da Fonseca, L. M., Menezes, C. C. B., Santos, C. A. D. N., de Lima, M. E. F., Decotè-Ricardo, D., Freire-de-Lima, M., da Costa, K. M., dos Reis, J. S., et al. (2021) · Medicines · doi:10.3390/medicines8100059 · Cited by 2
“Another study showed that the virus is capable of infecting 3D human brain organoids or, more precisely, neurons, within 2 days of exposure, causing their death [5].”
BackgroundExperimental Models of SARS-COV-2 Infection in the Central Nervous System
Paoletti, A. M., Melilli, M. G., & Vecchio, I. (2022) · Journal of Central Nervous System Disease · doi:10.1177/11795735221102231 · Cited by 1
Human Maternal-Fetal Interface Cellular Models to Assess Antiviral Drug Toxicity during Pregnancy
Herbek, S. L., Smithgall, M. C., Murphy, E. A., Schwartz, R. E., Chen, S., Riley, L. E., Stuhlmann, H., Yang, Y. J., & Goswami, R. (2022) · Reproductive Medicine · doi:10.3390/reprodmed3040024 · Cited by 1
Aging and Neurodegenerative Diseases: Why do Nerve Cells Die?
Klimaschewski, L. P. (2022) · Springer eBooks · doi:10.1007/978-3-662-66369-1_2 · Cited by 1
Blood brain barrier disruption following COVID-19 infection and neurological manifestations
Deshwal, S., Dhiman, N., & Sandhir, R. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-15256-6.00005-2 · Cited by 1
A systematic review of neurological symptoms and brain abnormalities in SARS-CoV-2 infections
Montoya, D. A. C., Albert, J., & López‐Martín, S. (2023) · Academia Medicine · doi:10.20935/acadmed6110 · Cited by 1
Telencephalic organoids as model systems to study cortical development and diseases
Yang, W. S., Kiral, F. R., & Park, I. (2024) · Organoid · doi:10.51335/organoid.2024.4.e1 · Cited by 1
3D Spheroid and Organoid Models to Study Neuroinfection of RNA Viruses
dos Reis, V. P., Cirksena, K., Rybak‐Wolf, A., Seeger, B., Herker, E., & Gerold, G. (2024) · Methods in molecular biology · doi:10.1007/978-1-0716-3926-9_26 · Cited by 1
It, F. E., Faivre, L. O., Thauvin‐Robinet, C., Vitobello, A., & Duplomb, L. (2024) · médecine/sciences · doi:10.1051/medsci/2024100 · Cited by 1
Katahira, I., Liebrand, N., Gorzkiewicz, M., Klahm, N. P., Abromavičiūtė, D., Werner, J., Krings, K. S., Orywol, S., Lautwein, T., Köhrer, K., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.115922 · Cited by 2
Hadjizadeh, A., Alavi, M., Tajvar, S., & Hadjizadeh, A. (2021) · Journal of Integrative Cardiology Open Access · doi:10.31487/j.jicoa.2021.03.07 · Cited by 1
Siddiqui, S. S., Aboshamat, K., Loganathan, S., & Siddiqui, Z. K. (2021) · Stem cell biology and regenerative medicine · doi:10.1007/978-3-030-78101-9_4 · Cited by 1
Karadağ, C., Gopalakrishnan, J., von Saß, C., Cornelius, J. F., Hänggi, D., van Lieshout, J. H., & Kamp, M. A. (2021) · Translational Stroke Research · doi:10.1007/s12975-021-00950-0 · Cited by 1
Self-citationDoença de Parkinson secundária a COVID-19: uma revisão sistemática
Hamoy, M., Braga, G. H. R., Chaves, J. V. S., Maia, A. C. S., Cabral, D. A. C., Campos, F. M. S., Medeiros, J. P. D. V., Cabral, L. G. C., Oliveira, B. P. D. S., Braga, J. P., et al. (2022) · Research Society and Development · doi:10.33448/rsd-v11i1.24397 · Cited by 1
Organoids: a new research model for SARS-CoV-2infection and treatment
Wang, T., Fan, S., & Chen, Y. (2021) · Scientia Sinica Vitae · doi:10.1360/ssv-2021-0294 · Cited by 1
Ostermann, P. N., Ramani, A., Bergmann, A., Adams, O., Gopalakrishnan, J., & Schaal, H. (2022) · Neuromethods · doi:10.1007/978-1-0716-2720-4_11 · Cited by 1
Self-citationStarting signal: Aberrant kinase activation as a trigger for SARS-CoV-2 induced axonal damage
Richards, A. L., & Jaenisch, R. (2022) · Frontiers in Virology · doi:10.3389/fviro.2022.973997 · Cited by 1
“Immunofluorescence imaging of SARS-CoV-2 infected cerebral organoids showed co-localization of the SARS-CoV-2 nucleocapsid protein with both neurons and neuronal progenitor cells further demonstrating the capacity of SARSCoV-2 to infect neural cells (28, 33).”
BackgroundCOVID-19 y placenta: afectación histopatológica y materno fetal
Campo, D. M. D., & Lozada, C. C. (2022) · Gaceta Médica de Caracas · doi:10.47307/gmc.2022.130.3.6 · Cited by 1
COVID-19 y cerebro fetal: afectación y secuelas
de Medicina, M. P. D. E. E. O. Y. G. D. D. P. E. M. M. F. U. C. D. V. M. C. A. N., & Cabrera-Lozada, C. (2022) · Gaceta Médica de Caracas · doi:10.47307/gmc.2022.130.4.15 · Cited by 2
Histomorphological Aspects of SARS-CoV-2-Induced Hippocampal Damage: A Case Series
Stoyanov, G. S., Petkova, L., Lyutfi, E., Stoyanov, D. S., Ivanov, M. N., & Tonchev, A. B. (2023) · Biomedical Reviews · doi:10.14748/bmr.v34.9611 · Cited by 1
The landscape of human brain immune response in patients with severe COVID-19Preprint
Fullard, J., Lee, H.-C., Voloudakis, G., Suo, S.-B., Shao, Z., Peter, C., Javidfar, B., Zhang, W., Jiang, S., Corvelo, A., et al. (2021) · bioRxiv · doi:10.1101/2021.01.08.425999 · Cited by 1
SARS-CoV-2 infection leads to Tau pathological signature in neuronsPreprint
Primio, C. D., Quaranta, P., Mignanelli, M., Siano, G., Bimbati, M., Piazza, C. R., Spezia, P. G., Perrera, P., Basolo, F., Poma, A. M., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.05.17.541098 · Cited by 1
Xu, Q., Wang, Y., He, Y., Zheng, X.-Q., Tong, M.-L., Yu, L., & Yang, T. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.01.23.576898 · Cited by 1
“Self-renewing and pluripotency properties of human pluripotent stem cells have greatly facilitated the understanding of the human nervous system development and pathogenesis of various neurological diseases(Mertens et al., 2016; Ramani et al., 2020).”
BackgroundXu, Q., Wang, Y., He, Y., Zheng, X.-Q., Tong, M.-L., Yu, L., & Yang, T. (2024) · eLife · doi:10.7554/elife.95197.2 · Cited by 2
Kettunen, P., Ruuska, J., Quirin, T., Ojha, R., Saber, S. H., Shaker, M., Morrison, S. D., Wolvetang, E. J., Joensuu, M., Koıstınaho, J., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.11.21.624622 · Cited by 1
Martí-Sarrias, A., Puertas, M. C., Turpín, I., Garrido-Sanz, L., Bayón-Gil, Á., Resa‐Infante, P., Chojnacki, J., García-Guerrero, M. C., Urrea, V., Lorenzo-Redondo, R., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.02.13.705720 · Cited by 1
“…have shown that SARS-CoV-2 infects brain organoids in vitro (Jacob et al., 2020; McMahon et al., 2021; Mesci et al., 2022; Pellegrini et al., 2020; Ramani et al., 2020; Samudyata et al., 2022; Song et al., 2021), the subsequent effects on neural tissue homeostasis and regeneration remain…”
Vavougios, G. D., Breza, M., Nikou, S., & Krogfelt, K. A. (2020) · Preprints.org · doi:10.20944/preprints202012.0739.v1
Manifestations neurologiques associées au COVID-19
Meppiel, E., & de Broucker, T. (2021) · Pratique Neurologique - FMC · doi:10.1016/j.praneu.2021.03.002 · Cited by 3
“Par ailleurs, des études in vitro et in vivo sur des souris transgéniques montrent que le SARSCoV-2 a la capacité d'infecter des neurones [54,55] mais sa capacité réplicative dans le tissu cérébral reste discutée.”
Samudyata, S., Oliveira, A. O., Malwade, S., de Sousa, N. R., Goparaju, S. K., Orhan, F., Steponaviciute, L., Sheridan, S. D., Perlis, R. H., Rothfuchs, A. G., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-724318/v1
Müller, L., Ostermann, P. N., Schaal, H., Salla, S., Timm, J., Geerling, G., & Menzel-Severing, J. (2022) · Pathogens · doi:10.3390/pathogens11020133
“Similarly, non-productive (abortive) SARS-CoV-2 infections have been described in neural tissue [24,27].”
BackgroundMethodInfluentialSelf-citationToward Understanding Neurodegeneration Using Brain Organoids
Wongtrakoongate, P., Pakiranay, C., & Kitiyanant, N. (2022) · Stem cell biology and regenerative medicine · doi:10.1007/978-3-030-93056-1_5 · Cited by 2
Understanding the cellular pathogenesis of COVID-19 symptoms using organoid technology
Che, Y. H., & Kim, Y. J. (2022) · Organoid · doi:10.51335/organoid.2022.2.e16
Immunadsorption zur Herstellung von COVID-19 Antikörperkonzentraten
Rothenburg, J., Rink‐Baron, S., Müller, L., Ostermann, P. N., Fischer, J., Stegbauer, J., & Moldenhauer, A. I. S. (2022) · Transfusionsmedizin · doi:10.1055/a-1720-8203
“Dabei wurde die Neutralisa-tion eines SARS-CoV-2 Wildtyp (D614G) Isolats (GISAID accession number: EPI_ISL_425126) gemessen [11].”
BackgroundSelf-citationAdvances in clinical molecular pathology research using organoid-based patient-derived models
Kuzumaki, N. (2022) · Folia Pharmacologica Japonica · doi:10.1254/fpj.22063
Neuropsychiatric side of the COVID-19
Mayorova, M. A., Churilov, L. P., Петрова, Н. Н., & Shoenfeld, Y. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-18566-3.00007-4
Sato, Y., Asahi, T., & Kataoka, K. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.02.11.528152
“which potentially served as a key to the development of therapeutic agents against severe acute 49 respiratory syndrome coronavirus 2 infections [2,3].”
BackgroundMorphological features of brain damage in severe COVID-19
Kanibolotskiy, A. A., & Zayratyants, O. V. (2023) · Journal of clinical practice · doi:10.17816/clinpract176827
Lyubimova, N. A., Pervunina, T. M., Ciel, K. A., & Kostik, M. M. (2023) · Russian Journal for Personalized Medicine · doi:10.18705/2782-3806-2023-3-2-46-56
Cao, Y., Feng, C., Chen, J., Liu, Y., Sheng, A., Li, S., Hu, Y., Yuan, C., Xie, J., & Zong, G. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.071025
Presumptive Molecular Interconnections Between COVID-19 And Huntington’s Disease
Ak, D. S., Alomarı, O., & Kılıç, Ü. (2024) · Clinical and Experimental Health Sciences · doi:10.33808/clinexphealthsci.1256952
Xu, Q., Wang, Y., He, Y., Zheng, X.-Q., Tong, M.-L., Yu, L., & Yang, T. (2024) · eLife · doi:10.7554/elife.95197.1
Xu, Q., Wang, Y., He, Y., Zheng, X.-Q., Tong, M.-L., Yu, L., & Yang, T. (2024) · eLife · doi:10.7554/elife.95197
Xie, Y., Xu, Z., Zhang, Y., Li, Y., Du, P., & Wang, C. (2024) · Journal of Biomedical Research · doi:10.7555/jbr.38.20240005
COVID-19 and its neurological effects
Singh, A., Srivastava, N., Kumar, S., & Singh, M. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95735-9.00006-1
Overview of Mechanisms Underlying Neuroimmune Diseases
Sonar, S. A., & Lal, G. (2024) · Springer eBooks · doi:10.1007/978-3-031-24297-7_1-1
Rashid, M. H., Singha, S., Arshad, F., & Sen, P. (2024) · Protein and Peptide Letters · doi:10.2174/0109298665333817240821111641 · Cited by 1
Psychoneurological disorders in the stage of post-COVID syndrome
Soldatenko, A. A., Николаевна, Г. Л., & Bobrik, Y. V. (2024) · Medical alphabet · doi:10.33667/2078-5631-2024-21-47-52
Overview of Mechanisms Underlying Neuroimmune Diseases
Sonar, S. A., & Lal, G. (2024) · Springer eBooks · doi:10.1007/978-3-031-60006-7_1
Diffuse changes in the brain in the acute phase of COVID-19 and after infection
Berliand, A. N., Ануфриев, П. Л., & Kanibolotskiy, A. A. (2025) · Russian Journal of Archive of Pathology · doi:10.17116/patol2025870115
Cytokine profiles and neurological manifestations in post-COVID syndrome
Desheva, Y. A., Muruzheva, Z. M., Tumashova, O. S., Shvedova, T. N., Kudar, P. A., Matveev, G. A., Koroleva, I. V., Leontieva, G., Lerner, A. A., Ponkratov, S. V., et al. (2025) · Exploration of Immunology · doi:10.37349/ei.2025.1003184 · Cited by 1
Novel Real-Time EEG Signal Decoding Algorithm based on Deep Learning
Jin, H., Jin, Z., Kim, Y.-G., & Li, K. (2025) · International Conference on Electronics and Renewable Systems (ICEARS) · doi:10.1109/icears64219.2025.10940534
Grossberg, A. N. (2024) · Digital Commons - DU (University of Denver) · doi:10.56902/etdcrp.2024.14
Organoid (3D-cell) cultures in the assessment of cross-species virus transmission
Kuznetsova, T. A., Galkina, I. V., Kryzhanovsky, S. P., & MIu, S. (2025) · Journal of microbiology epidemiology immunobiology · doi:10.36233/0372-9311-628
Bioengineering Organoids for Disease Modeling and Drug Discovery
Mandal, K., Wahane, S., Nihad, M., Mukherjee, A., Bisht, B., Mukhopadhyay, C., Bose, B., & Paul, M. K. (2025) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815238693125010003
Respiratory System-Based In Vitro Antiviral Drug Repurposing Strategies for Sars-Cov-2
Genc, D., Katı, A., Mandal, A. K., Ghorai, S., Salami, H., ElHefnawi, S. N. K., & Altuntaş, S. (2025) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815238693125010008
Rathinam, D., Jadhav, V., Wasim, S., Elkahwagy, D., Altinisik, N., Cicek, E., Borkar, T., Mariappan, A., Vinchure, O. S., Poempner, N., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.08.01.668123 · Cited by 1
Self-citationCircadian Regulation of the Immune System and Susceptibility to COVID-19
Zeng, Z. (2025) · Transactions on Materials Biotechnology and Life Sciences · doi:10.62051/wemwd548
Additional file 8 of Integrative single-cell RNA-seq analysis of vascularized cerebral organoids
Sato, Y., Asahi, T., & Kataoka, K. (2024) · Figshare · doi:10.6084/m9.figshare.26636634
Additional file 14 of Integrative single-cell RNA-seq analysis of vascularized cerebral organoids
Sato, Y., Asahi, T., & Kataoka, K. (2024) · Figshare · doi:10.6084/m9.figshare.26636652
Lengacher, N. A., Tomlinson, J. J., Jochum, A.-K., Franz, J., Ali, O. H., Flatz, L., Jochum, W., Penninger, J., Stadelmann, C., Woulfe, J. M., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26715505
Bauer, L., Rissmann, M., Benavides, F. F. W., Leijten, L. M. E., van Run, P., Begeman, L., Kroeze, E. J. B. V., Lendemeijer, B., Smeenk, H., de Vrij, F. M. S., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20921251
Additional file 5 of Integrative single-cell RNA-seq analysis of vascularized cerebral organoids
Sato, Y., Asahi, T., & Kataoka, K. (2024) · Figshare · doi:10.6084/m9.figshare.26636625
Additional file 10 of Integrative single-cell RNA-seq analysis of vascularized cerebral organoids
Sato, Y., Asahi, T., & Kataoka, K. (2024) · Figshare · doi:10.6084/m9.figshare.26636640
Carneiro, V. C. D. S., Alves‐Leon, S. V., Sarmento, D. J. D. S., Coelho, W. L. D. C. N. P., Moreira, O. D. C., Salvio, A. L., Ramos, C. H. F., Filho, C. H. F. R., Marques, C. A. B., da Costa Gonçalves, J. P., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20033160
Additional file 6 of Integrative single-cell RNA-seq analysis of vascularized cerebral organoids
Sato, Y., Asahi, T., & Kataoka, K. (2024) · Figshare · doi:10.6084/m9.figshare.26636628
Additional file 11 of Integrative single-cell RNA-seq analysis of vascularized cerebral organoids
Sato, Y., Asahi, T., & Kataoka, K. (2024) · Figshare · doi:10.6084/m9.figshare.26636643
Metadata
- Authors
- Ramani, A., Müller, L., Ostermann, P. N., Gabriel, E., Abida‐Islam, P., Müller‐Schiffmann, A., Mariappan, A., Goureau, O., Gruell, H., Walker, A., Andrée, M., Hauka, S., Houwaart, T., Dilthey, A., Wohlgemuth, K., Omran, H., Klein, F., Wieczorek, D., Adams, O., Timm, J., Korth, C., Schaal, H., & Gopalakrishnan, J.
- Affiliations
- Düsseldorf University Hospital (DE)
- Centre National de la Recherche Scientifique (FR)
- University of Cologne (DE)
- University Hospital Münster (DE)
- Corresponding author
- Schaal, Heiner
- Gopalakrishnan, Jay
- ORCID
- Ramani, Anand
- Müller, Lisa
- Ostermann, Philipp N
- Gabriel, Elke
- Müller‐Schiffmann, Andreas
- Mariappan, Aruljothi
- Goureau, Olivier
- Gruell, Henning
- Walker, Andreas
- Houwaart, Torsten
- Dilthey, Alexander
- Wohlgemuth, Kai
- Omran, Heymut
- Wieczorek, Dagmar
- Adams, Ortwin
- Timm, Jörg
- Korth, Carsten
- Schaal, Heiner
- Gopalakrishnan, Jay
- Venue
- The EMBO Journal
- Published
- 2020-09-23
- Volume
- 39
- Issue
- 20
- Pages
- e106230-e106230
- ISSN
- 0261-4189 (ISSN-L)
- 1460-2075
- PMC
- PMC7560208
- OpenAlex
- W3081536095
- Cited by
- 518
- References
- 63
- Citations by year
- 2026: 16 · 2025: 39 · 2024: 71 · 2023: 85 · 2022: 126 · 2021: 145 · 2020: 36
- FWCI
- 42.41
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- other-oa
- creativecommons.org/licenses/by-nc-nd/4.0/ (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0/ (vor)
- Locations
- The EMBO Journal (publishedVersion, other-oa)
- bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Kölner Universitäts PublikationsServer (Universität zu Köln) (publishedVersion)
- HAL (submittedVersion, other-oa)
- Funders
- Fritz Thyssen Stiftung (10.17.2.018MN)
- Juergen Manchot Foundation
- Topics
- Health Sciences › Medicine › Clinical Neurology › Long-Term Effects of COVID-19
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Keywords
- SARS-CoV-2, COVID-19 pandemic, brain organoids, neuronal infection, neurotoxicity, tau hyperphosphorylation, neuronal cell death, central nervous system pathology
- MeSH terms
- Betacoronavirus, SARS-CoV-2, Animals, Brain, Chlorocebus aethiops, Humans, Nervous System Diseases, Neurons, Organoids, Vero Cells, tau Proteins, Cell Death
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.